Need an investment idea? Check out Popular Stocks and S2O Stock Screener.

Market Price

60.00 

2.00 3.5%

as of May 20 '22

52 Week Range:

41.00 74.50


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for health care practitioners and their patients in the United States. The company develops products based on its proprietary DepoFoam product delivery technology that encapsulates drugs without altering their molecular structure. It offers EXPAREL, a bupivacaine liposome injectable suspension, administered at the time of surgery to control pain and reduce or eliminate the use of opioids for acute postsurgical pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature only to targeted nerves. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Parsippany, New Jersey.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Equity (BVPS) 0.42
1.86
1.06
3.53
5.19
5.40
5.45
6.39
7.39
10.94
14.14
growth rate 342.9% -43.0% 233.0% 47.0% 4.1% 0.9% 17.3% 15.7% 48.0% 29.3%
Earnings BIT -5.17
9.46
-32.02
-19.49
17.48
35.71
51.52
growth rate 100.0% -100.0% 0.0% 100.0% 104.3% 44.3%
Avg.PE -27.11
-16.37
-16.37
-16.37
-16.37
18.13
growth rate 0.0% 0.0% 0.0% 0.0% 100.0%
ROA -48.13
-46.36
-45.35
-5.53
0.52
-9.72
-8.36
-0.07
-1.45
13.82
2.51
growth rate 0.0% 0.0% 0.0% 100.0% -100.0% 0.0% 0.0% 0.0% 100.0% -81.8%
ROE -91.62
-119.34
-12.92
0.95
-17.35
-17.10
-0.16
-3.26
29.86
6.22
growth rate 0.0% 0.0% 100.0% -100.0% 0.0% 0.0% 0.0% 100.0% -79.2%
ROIC -63.68
-37.35
-4.14
2.50
-10.03
-6.80
1.65
-0.06
17.06
4.17
growth rate 0.0% 0.0% 100.0% -100.0% 0.0% 100.0% -100.0% 100.0% -75.6%
Cur. Ratio 2.59
4.30
0.88
1.53
1.67
5.42
6.96
7.88
3.79
2.57
1.66
growth rate 66.0% -79.5% 73.9% 9.2% 224.6% 28.4% 13.2% -51.9% -32.2% -35.4%
Quick Ratio 2.45
3.21
0.71
1.28
1.22
4.52
6.10
6.95
3.15
2.27
1.44
growth rate 31.0% -77.9% 80.3% -4.7% 270.5% 35.0% 13.9% -54.7% -27.9% -36.6%
Leverage 2.35
1.70
4.12
1.91
1.78
1.79
2.25
2.14
2.34
2.06
2.84
growth rate -27.7% 142.4% -53.6% -6.8% 0.6% 25.7% -4.9% 9.4% -12.0% 37.9%
Balance Sheet Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Acct.Receivable 22.37
25.86
29.94
31.66
38.00
48.93
54.65
growth rate 15.6% 15.8% 5.8% 20.0% 28.8% 11.7%
Acct.Payable 6.76
8.74
7.51
14.66
14.37
12.80
10.43
growth rate 29.3% -14.1% 95.2% -2.0% -10.9% -18.5%
Cur.Assets 214.26
252.58
243.09
391.11
477.97
408.56
651.62
growth rate 17.9% -3.8% 60.9% 22.2% -14.5% 59.5%
Total Assets 326.07
387.74
391.47
628.37
689.35
831.07
1,274.51
growth rate 18.9% 1.0% 60.5% 9.7% 20.6% 53.4%
Cash 37.52
56.98
35.94
54.13
132.53
78.23
99.96
growth rate 51.9% -36.9% 50.6% 144.9% -41.0% 27.8%
Inventory 29.26
61.65
31.28
41.41
48.57
58.30
64.65
growth rate 110.7% -49.3% 32.4% 17.3% 20.0% 10.9%
Cur.Liabilities 140.01
149.79
44.84
56.22
60.66
107.67
253.33
growth rate 7.0% -70.1% 25.4% 7.9% 77.5% 135.3%
Liabilities 154.93
169.34
172.49
348.89
368.13
476.12
654.83
growth rate 9.3% 1.9% 102.3% 5.5% 29.3% 37.5%
LT Debt 108.74
276.17
290.59
306.05
313.03
growth rate 154.0% 5.2% 5.3% 2.3%
Equity 171.15
218.39
218.98
279.48
321.23
354.94
619.69
growth rate 27.6% 0.3% 27.6% 14.9% 10.5% 74.6%
Common Shares 16.00
30.00
33.00
35.00
41.00
37.00
40.00
41.00
42.00
44.00
46.00
growth rate 87.5% 10.0% 6.1% 17.1% -9.8% 8.1% 2.5% 2.4% 4.8% 4.6%
Cash Flow Statement Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Capital Expenditures 22.98
40.30
24.71
19.27
14.51
10.16
37.80
growth rate 75.3% -38.7% -22.0% -24.7% -30.0% 272.1%
Cash From OA 26.56
28.02
33.45
17.79
48.87
70.52
77.03
growth rate 5.5% 19.4% -46.8% 174.8% 44.3% 9.2%
FCF per Share -2.46
-1.99
-1.59
-0.29
-0.33
0.10
-0.02
0.58
1.25
0.54
1.90
growth rate 0.0% 0.0% 0.0% 0.0% 100.0% -100.0% 100.0% 115.5% -56.8% 251.9%
Sale Purchase of Stock 118.88
12.17
7.27
8.64
growth rate -89.8% -40.3% 18.9%
FCF -37.00
-88.00
-56.00
4.00
-12.00
9.00
-1.00
34.00
60.00
39.00
80.00
growth rate 0.0% 0.0% 100.0% -100.0% 100.0% -100.0% 100.0% 76.5% -35.0% 105.1%
Income Statement Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Sales 197.67
249.00
276.37
286.63
337.28
421.03
429.65
growth rate 26.0% 11.0% 3.7% 17.7% 24.8% 2.1%
Op.Income -5.17
9.46
-32.02
-19.49
17.48
35.71
51.52
growth rate 100.0% -100.0% 0.0% 100.0% 104.3% 44.3%
IBT -13.54
2.12
-37.84
-42.47
-0.43
-10.75
20.09
growth rate 100.0% -100.0% 0.0% 0.0% 0.0% 100.0%
Net Income -13.72
1.86
-37.95
-42.61
-0.47
-11.02
145.52
growth rate 100.0% -100.0% 0.0% 0.0% 0.0% 100.0%
EPS -2.64
-1.72
-1.93
-0.39
0.04
-1.02
-1.07
-0.01
-0.27
3.33
0.92
growth rate 0.0% 0.0% 0.0% 100.0% -100.0% 0.0% 0.0% 0.0% 100.0% -72.4%
Gross Profit 101.50
148.50
120.59
142.00
194.74
242.20
252.90
growth rate 46.3% -18.8% 17.8% 37.1% 24.4% 4.4%
R&D 57.29
57.29
57.29
57.29
55.69
59.42
59.42
growth rate 0.0% 0.0% 0.0% -2.8% 6.7% 0.0%

Quarterly Statements

Item Name Sep '20 Dec '20 Mar '21 Jun '21 Sep '21
Earnings BIT 18.31
25.55
21.31
34.99
30.72
growth rate 39.5% -16.6% 64.2% -12.2%
Balance Sheet Sep '20 Dec '20 Mar '21 Jun '21 Sep '21
Acct.Receivable 47.74
54.65
53.38
69.26
50.38
growth rate 14.5% -2.3% 29.7% -27.3%
Acct.Payable 13.01
10.43
9.11
12.18
7.90
growth rate -19.8% -12.7% 33.7% -35.2%
Cur.Assets 658.52
651.62
720.25
792.58
822.35
growth rate -1.1% 10.5% 10.0% 3.8%
Total Assets 1,220.27
1,274.51
1,287.55
1,325.83
1,356.00
growth rate 4.5% 1.0% 3.0% 2.3%
Cash 125.24
99.96
66.70
105.77
134.04
growth rate -20.2% -33.3% 58.6% 26.7%
Inventory 68.54
64.65
64.61
65.26
67.21
growth rate -5.7% -0.1% 1.0% 3.0%
Cur.Liabilities 86.27
253.33
232.08
228.69
225.79
growth rate 193.6% -8.4% -1.5% -1.3%
Liabilities 635.58
654.83
636.73
638.67
637.40
growth rate 3.0% -2.8% 0.3% -0.2%
LT Debt 456.46
313.03
317.34
321.71
326.15
growth rate -31.4% 1.4% 1.4% 1.4%
Equity 584.69
619.69
650.82
687.17
718.60
growth rate 6.0% 5.0% 5.6% 4.6%
Common Shares 0.04
0.04
0.04
0.04
0.05
growth rate 2.3% 0.0% 0.0% 2.3%
Cash Flow Statement Sep '20 Dec '20 Mar '21 Jun '21 Sep '21
Capital Expenditures 7.76
14.41
13.07
10.55
13.08
growth rate 85.6% -9.3% -19.3% 23.9%
Cash From OA 39.78
46.67
12.08
30.13
60.29
growth rate 17.3% -74.1% 149.4% 100.1%
Sale Purchase of Stock
growth rate
FCF 32.02
32.26
-0.99
19.58
47.21
growth rate 0.8% -100.0% 100.0% 141.1%
Income Statement Sep '20 Dec '20 Mar '21 Jun '21 Sep '21
Sales 117.48
130.97
119.03
135.59
127.72
growth rate 11.5% -9.1% 13.9% -5.8%
Op.Income 18.31
25.55
21.31
34.99
30.72
growth rate 39.5% -16.6% 64.2% -12.2%
IBT 6.15
12.69
12.72
25.65
24.23
growth rate 106.4% 0.2% 101.6% -5.5%
Net Income 130.12
14.52
10.37
19.08
17.66
growth rate -88.8% -28.6% 84.0% -7.5%
Gross Profit 72.84
80.35
71.80
87.77
81.49
growth rate 10.3% -10.6% 22.2% -7.2%
R&D 15.33
15.33
growth rate 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

B (74.77)

YOY Growth Grade:

D (37.27)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 18.13 21.75
EPS / Growth 2.76

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 36.8%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 36.8% 36.8% 36.8%
Future PE 0.01 12.09 30.57
Future EPS 63.22 63.22 63.22
Value Price
MOS %
0.16
-99.7%
188.92
214.9%
477.63
696.0%
MOS Price 0.08 94.46 238.81
IRT 6.13 6.13 6.13

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.